Background: Three isoforms of NO synthase (NOS) have been identified: endothelial NOS, neuronal NOS, and inducible NOS (iNOS). The enhanced expression of iNOS, at the protein level, has been reported previously in certain chemically induced oral carcinomas in hamster buccal-pouch mucosa, however, the corresponding expression of iNOS, at the mRNA level, has not yet been demonstrated. The purpose of the present study is to assess the iNOS mRNA expression level in 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccalpouch carcinomas using a reverse transcription-polymerase chain reaction (RT-PCR). Methods: Thirty-three outbred, young (six-weeks old), male, Syrian golden hamsters (Mesocricatus auratus) were randomly divided into one experimental group (13 animals) and two control groups (10 animals each). The pouches of a group of 13 animals of the experimental group were bilaterally painted with a 0.5% DMBA solution three times a week for 12 weeks. Each animal of one control group was similarly treated with mineral oil only, while the other control group of 10 animals remained untreated throughout the experiment. Results: Areas of dysplasia and squamous-cell carcinomas, with a 100% tumor incidence, developed for all of the DMBAtreated buccal pouches. The mineral oil-treated and untreated pouches had no obvious changes. A band of 499-bp, corresponding to iNOS mRNA, was present in all the DMBA-treated hamster buccal-pouch mucosa animals, but not in the untreated animals or the animals treated with mineral oil. Upon direct sequencing, this 499-bp band was confirmed to be part of the iNOS gene. Conclusions: This study demonstrated that increased iNOS mRNA expression could contribute to the mechanism for experimentally induced oral carcinogenesis.
from a family of enzymes named NO synthase (NOS; E.C.1.14. 13.39) that convert L-arginine to L-citrulline and thus generate NO (2) . Three isoforms of NO have been identified and characterized to date: two of them (endothelial NOS or eNO, a 132-kDa protein and neuronal NOS or nNOS, a 162-kDa protein) are present constitutively and are calcium dependent. The other isoform (inducible NOS or iNOS, a 130-kDa protein), which is induced in the body during the inflammatory processes, is calcium independent (3).
Nitric oxide reacts rapidly and nonenzymatically with the superoxide anion to form a peroxynitrite anion, a highly toxic molecule which is responsible for eliciting a wide range of DNA damage and protein modifications (4) . The peroxynitrite ion can also react directly with a variety of enzymes and other proteins to either activate or inhibit their functions by oxidizing SH groups, complexing with metal ions, or reacting with tyrosine (5) . All of these effects of NO could be essential to its participation in carcinogenesis.
The hamster buccal-pouch mucosa provides one of the most widely accepted experimental models for oral carcinogenesis (6) .
Despite anatomical and histological differences between (hamster) pouch mucosa and human buccal tissue, experimental carcinogenesis protocols for the former induce premalignant changes and carcinomas that are similar to the development of premalignancy and malignancy in human oral mucosa (7) . To date, little is known of the role of NO in experimentally induced oral carcinogenesis. The purpose of this study was to investigate the mRNA expression of iNOS for 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal-pouch carcinomas.
Materials and methods

Hamsters and treatments
Thirty-three outbred, young (six-weeks old), male, Syrian golden hamsters (Mesocricatus auratus) (purchased from National Science Council Animal Breeding Centre, Taipei, ROC), weighing about 100 g each at the commencement of the experiment, were randomly allocated to the experimental group (13 animals) or one of the two control groups (10 animals each). The animals were housed under constant conditions (22aeC, 12 h light/dark cycle) and fed with tap water and standard Purina laboratory chow ad libitum. The animalhandling protocol ensured that the test animals were humanely treated throughout the experimental process. Subsequent to allowing the animals to acclimatize to their new surroundings for one week, both pouches of the 13 animals in the experimental group were painted with a 0.5% DMBA solution at 9 a.m. on the Monday, Wednesday and Friday of each week, using a no. 4 sable-hair brush.
Both pouches of each animal of one of the control groups were similarly treated by topical application of approximately 0.2 ml mineral oil to the medial walls of both pouches at each painting. Another control group of 10 animals remained untreated throughout the experiment.
After 12 weeks of such treatment (three days after the last treatment), to avoid the potential influence of any diurnal variation (8) , all the animals from each group were simultaneously killed at 9a.m., using a lethal dose of diethyl ether. The animals' pouches were exposed by dissection, and cut from the oral opening to the caudal ends along the middle of the lateral walls and examined grossly.
Both pouches were then excised. A portion of the pouch tissue was immediately frozen in liquid nitrogen for subsequent RNA extraction, and another portion was fixed in 10% neutral-buffered formalin solution, dehydrated in ascending alcohols, cleared in xylene, and embedded in paraffin for light microscopy.
Extraction of RNA
Total RNA was extracted by homogenizing the hamster buccalpouch tissue specimens in guanidium isothiocyanate followed by ultracentrifugation in caesium chloride, as described previously (9) .
The RNA concentration was determined from the optical density at a wavelength of 260 nm (using an OD 260 unit equivalent to 40 mg/ml of RNA). In brief, the pouch tissue (ϳ250 mg) was added to 500 ml of denaturing solution (4 M guanidium thiocyanate, 25 mM sodium citrate [pH ϭ 7.0], 0.5% sodium N-sarosine) with 50 ml of 2M NaOAc (pH ϭ 4.0), 500 ml of water-saturated phenol, and 100 ml of chloroform:isoamyl alcohol (1 : 1, v/v). The homogenized pouch tissue, plus solution, was then vortexed thoroughly. The RNA was subsequently precipitated with an equal volume of isopropanol. The pellet was rinsed twice with 1 ml of 75% ethanol and dried in air. The RNA was resuspended in 100 ml of diethlpyrocarbonate (DEPC)-treated water at a final concentration of 1 mg/ml and stored at ª80aeC until further use.
Reverse transcription reaction (cDNA synthesis)
Isolated total RNA (1 mg) was reverse-transcribed to cDNA in a reaction mixture (with a final volume of 20 ml) containing 4 ml of MgCl 2 (5 mM), 2 ml of 10 x reverse transcription buffer (10 mM Tris-HCl [pH ϭ 9.0], 50 mM KCl, 0.1% TritonA X-100), 2 ml of dNTP mixture (1 mM each), 0.5 ml of recombinant RNasinA ribnonuclease inhibitor (1 m/ml), 15 units of avian-myeloblastosis-virus (AMV) reverse transcriptase (High Conc.) (15 m/mg), 0.5 mg of oligo(dT) 15 primer (Promega, catalogue no. A3500, WI, USA). The reaction mixture was incu- Table 1 .
The 20 ml first-strand cDNA-synthesis reaction product obtained from the reverse transcriptase (RT) reaction was diluted to 100 ml with nuclease-free water. The PCR amplification reaction mixture (with a final volume of 100 ml) contained 20 ml of diluted, first-strand cDNA reaction product (Ͻ 10 ng/ml), 2 ml of cDNA reaction dNTPs The PCRs were carried out on a DNA thermal cycler (TaKaRa MP, Tokyo, Japan). Thermocycling conditions included denaturing at 94 aeC for one minute (one cycle), then denaturing at 94 aeC (60 s), annealing at 55 aeC (60 s) for iNOS or at 60 aeC (60 s) for b-actin, and extending at 72 aeC (60 s) for 30 cycles and a final extension at 72 aeC for seven minutes. The b-actin primers were utilized as positive controls. Negative controls without RNA and without reverse transcriptase were also performed. Amplification products were analyzed by electrophoresis in a 2% agarose gel along with the DNA molecular weight marker (Boehringer Mannheim, Mannheim, Germany) containing ethidium bromide. The PCR products were visualized as bands with a UV transilluminator. Photographs were taken with a Polaroid DS-300 camera. The PCR products were then sequenced to confirm their identities using a T7 Sequenase kit (version 2.0, Amersham International, Little Chalfont, UK).
Results
Gross observations and histopathology
Gross and histopathological changes in the 12-week DMBA-treated pouches were similar to those described in our previous study (12) .
Areas of dysplasia and squamous-cell carcinomas ( Fig. 1) with a 100% tumor incidence were apparent for all of the 12-week DMBAtreated pouches. The mineral oil-treated and untreated pouches revealed no obvious changes.
Reverse transcription-polymerase chain reaction
A band corresponding to 499-bp was observed for all the hamster buccal-pouch tissue specimens treated with DMBA for 12 weeks (Fig. 2) . Upon direct sequencing, this 499-bp band was confirmed to be part of the iNOS gene. No such bands were noticed for the untreated animals, the mineral oil-treated tissues and the negativecontrol samples (Fig. 2) . All samples, except the negative-control samples, revealed bands of b-actin (350-bp) (Fig. 2) .
iNOS mRNA in DMBA-carcinogenesis 
Discussion
The expression of iNOS mRNA in chemically induced oral carcinomas has not, to the best of our knowledge, been reported previously for hamster buccal-pouch mucosa. Using RT-PCR, iNOS mRNA was predominantly found in the DMBA-treated pouch carcinomas in the current study, however, the expression of mRNA of iNOS has already been noted for patients demonstrating gastric carcinomas (13) . This suggests that the high activity of iNOS mRNA may be closely related to chemically induced oral carcinogenesis.
The current study merely shows that iNOS mRNA is over-ex- the discovery that NO and its derivatives are produced in copious quantities in inflamed tissues (16) . Such a high level of NO following inflammation, without homeostatic regulation, may then lead to DNA damage and mutations (16) . Despite it being a subject of some conjecture, it is worth considering that due to epi- Recently, iNOS expression was correlated with p53 for human oral epithelial dysplasia (22) and oral squamous-cell carcinoma (23) .
It therefore appears worthwhile to attempt to verify whether a similar correlation exists between NOS and p53 in cases of DMBAinduced hamster buccal-pouch carcinogenesis. Subsequent work focusing upon the interaction between iNOS and p53 in DMBA-induced hamster buccal-pouch carcinogenesis may provide a new insight into the mechanism of chemically induced carcinogenesis in the oral cavity.
Inducible NOS protein has been induced in premalignant and malignant, but not normal, clinical specimens obtained from stomach (24) , colon (25) , lung (26) , esophagus (27) , prostate (28) , and the oral cavity (22, 23, 29, 30) , suggesting that iNOS is an immunohistochemical marker for these malignant neoplasia. Being assessed at an mRNA level in the present study, we have also demonstrated that iNOS is a valuable marker at an mRNA level for DMBA-induced hamster buccal-pouch carcinomas.
The enhanced expression of iNOS mRNA in DMBA-induced hamster buccal-pouch carcinomas, compared with the untreated and mineral oil-treated counterparts in the current study, is consistent with our previous work using immunohistochemical techniques at the protein level (12) . This suggests that iNOS gene expression may be regulated at the level of mRNA, however, more studies needs to be conducted done to unravel the molecular mechanism(s) that regulate the increased iNOS mRNA expression in experimentally induced oral carcinogenesis.
